Summary
- Current Price
- As of today, MRK price is $122.26, up +0.33% on
- Current Price All-Time High
- MRK price is currently -9.19% below its historical high of $134.63 set on
- Market Cap
- MRK current market cap is $305B, up +37.88% over the past 365 days
- PE Ratio
- MRK current PE ratio is 16.81
- Revenue
- MRK current annual revenue is $65.01B, up +1.62% year-over-year
- Next Earnings
- The next earnings release for MRK is on
Profile
| Metric | Value |
|---|---|
| Full Name | Merck & Co., Inc. |
| Ticker | NYSE: MRK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | merck.com |
| Employees | 73,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $122.26 | |
| Price, 1D Change | +0.33% | |
| Market Cap | $305B | |
| TTM Dividend Yield | 2.68% | |
| PE Ratio | 16.81 | |
| Beta | 0.41 | |
| Revenue | $65B | |
| Revenue, 1Y Change | +1.62% | |
| EPS | $7.28 | |
| EPS, 1Y Change | +8.09% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.85 | |
| Next Ex-Dividend | $0.85 | |
| Last Split | 131:125 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $7.28 | |
| EPS Estimate | N/A | $5.13 |
| EPS Est. Change | N/A | -29.52% |
| Revenue | $65.01B | |
| Revenue Estimate | N/A | $66.72B |
| Revenue Est. Change | N/A | +2.62% |
| Current Price | $122.26 | |
| Price Target | - | $130.00 |
| Price Tgt. Change | - | +6.33% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.62 | $6.74 | -11.61% | |
| $8.94 | $7.28 | -18.52% | |
| $5.13 | N/A | -29.52% | |
| $9.79 | N/A | +34.47% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $64.00B | $63.97B | -0.04% | |
| $64.80B | $65.01B | +0.33% | |
| $66.72B | N/A | +2.62% | |
| $70.39B | N/A | +8.28% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +39.44% | |
| Price, 3Y | +11.63% | |
| Market Cap, 1Y | +37.88% | |
| Market Cap, 3Y | +9.84% | |
| Revenue, 1Y | +1.62% | |
| Revenue, 3Y | +11.18% | |
| EPS, 1Y | +8.09% | |
| EPS, 3Y | +27.48% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $122.26 | |
| SMA 200 | $90.53 | |
| SMA 200 vs Price | -25.95% | |
| SMA 50 | $109.71 | |
| SMA 50 vs Price | -10.27% | |
| Beta | 0.41 | |
| ATR | $2.89 | |
| 14-Day RSI | 70.81 | |
| 10-Day Volatility | 24.93% | |
| 1-Year Volatility | 29.16% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.85 | |
| Upcoming | $0.85 | |
| Dividend Yield | 2.68% | |
| Total Dividend | $3.28 | |
| Dividends Paid | - | |
| Payout Ratio | - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $65.01B | |
| EPS | $7.28 | |
| Gross Profit | $52.98B | |
| Gross Margin | 81.50% | |
| Operating Profit | $26.78B | |
| Operating Margin | 41.19% | |
| Net Income | $18.26B | |
| Net Margin | 28.09% | |
| EBITDA | - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | - | |
| Current Ratio | - | |
| Quick Ratio | - | |
| - | ||
| F-Score | - | |
| Altman Z-Score | - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 16.81 | |
| PS Ratio | 4.70 | |
| PB Ratio | - | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | - | |
| Cash & Equivalents | - | |
| Total Assets | - | |
| Current Assets | - | |
| Total Liabilities | - | |
| Current Liabilities | - | |
| Total Debt | $0.00 | |
| Short Term Debt | - | |
| Accounts Payable | - |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $46.76B | |
| Operating Expenses | $26.21B | |
| Cost Of Goods Sold | $12.03B | |
| SG&A | $0.00 | |
| D&A | - | |
| Interest Expense | $0.00 | |
| Income Tax | $2.80B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | - | |
| CFI | - | |
| CFF | - | |
| Capex | - | |
| Free Cash Flow | - |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Guggenheim | → | |
| Wells Fargo | → | |
| Citigroup | → | |
| Cantor Fitzgerald | → | |
| Citigroup | → | |
| TD Cowen | → | |
| Wolfe Research | → | |
| UBS | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with MRK
FAQ
What is the ticker symbol for Merck & Co., Inc.?
The ticker symbol for Merck & Co., Inc. is NYSE:MRK
Does Merck & Co., Inc. pay dividends?
Yes, Merck & Co., Inc. pays dividends. The last payment was $0.85, with an ex-dividend date on December 15, 2025
What sector is Merck & Co., Inc. in?
Merck & Co., Inc. is in the Healthcare sector
What industry is Merck & Co., Inc. in?
Merck & Co., Inc. is in the General Drug Manufacturers industry
What country is Merck & Co., Inc. based in?
Merck & Co., Inc. is headquartered in United States
When did Merck & Co., Inc. go public?
Merck & Co., Inc. initial public offering (IPO) was on January 13, 1978
Is Merck & Co., Inc. in the S&P 500?
Yes, Merck & Co., Inc. is included in the S&P 500 index
Is Merck & Co., Inc. in the NASDAQ 100?
No, Merck & Co., Inc. is not included in the NASDAQ 100 index
Is Merck & Co., Inc. in the Dow Jones?
Yes, Merck & Co., Inc. is included in the Dow Jones index
When was Merck & Co., Inc. last earnings report?
Merck & Co., Inc.'s most recent earnings report was on February 3, 2026
When does Merck & Co., Inc. report earnings?
The next expected earnings date for Merck & Co., Inc. is April 30, 2026
Data Sources & References
- MRK Official Website www.merck.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of Dow Jones Industrial Average Companies en.wikipedia.org/wiki/Dow_Jones_Industrial_Average
- MRK Profile on Yahoo Finance finance.yahoo.com/quote/MRK
- MRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrk
